Polyethylene Glycol (PEGs & PEOs)

DSPE-PEG-OH, MW 2K is a PEG derivative containing a DSPE group and a hydroxyl group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other

DSPE-PEG12-Mal is a PEG derivative with a DSPE and maleimide group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

DSPE-PEG12-Mal is a PEG derivative with a DSPE and maleimide group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

DSPE-PEG13-TFP is a PEG derivative with a DSPE moiety and activated TFP ester. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic

DSPE-PEG13-TFP is a PEG derivative with a DSPE moiety and activated TFP ester. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic

DSPE-PEG4-acid is a PEG derivative containing DSPE and carboxylic acid moieties. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic

DSPE-PEG4-acid is a PEG derivative containing DSPE and carboxylic acid moieties. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic

DSPE-PEG4-DBCO is a PEG derivative containing DSPE and DBCO moieties. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

DSPE-PEG4-DBCO is a PEG derivative containing DSPE and DBCO moieties. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

DSPE-PEG4-DBCO is a PEG derivative containing DSPE and DBCO moieties. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The

DSPE-PEG8-Mal is a PEG derivative with attached DSPE and maleimide groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs.

DSPE-PEG8-Mal is a PEG derivative with attached DSPE and maleimide groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs.